Pharma and Biotech Competitive Intelligence

Why AlphaSense is the Leading Comp Intel Tool For Biopharma

AlphaSense is a leading provider of competitive intelligence, aggregating 10,000+ high-qualitycontent sources that cover hundreds of thousands of public companies and over 1.4 million private companies—all in a single platform.

Our platform is consistently ranked as an industry leader by G2 and TrustRadius, and was recognized as one of the top 50 AI companies by Forbes.

Competitive strategists and decision makers in the pharmaceutical and biotechnology sectors have access to exclusive competitive data ordinarily found in disparate locations and often behind expensive paywalls. With AlphaSense, organizations can conduct comprehensive quantitative and qualitative market research that results in smarter strategic decision-making.

AlphaSense aggregates premium content from across the key perspectives of research—company, journalist, analyst, regulatory, and expert—all indexed and easily searchable.

AlphaSense also saves you hours of research time by centralizing the insights you need and delivering them to you with intelligent, AI-based smart search technology—maximizing confidence and minimizing informational blind spots.

Here’s how AlphaSense supports you in every step of your competitive intelligence journey:

Trusted by the world's leading corporations

95%
of the top consultancies
80%
of the top asset management firms
20
largest pharmaceutical companies
88%
of the S&P 100

Components of Effective Competitive Intelligence in Biopharma

Competitor Analysis

To perform a competitive analysis, you need to study your competitor’s business in order to understand their strengths and weaknesses. This includes looking at their product offerings, pipelines, pricing strategies, commercialization campaigns, licensing deals, R&D efforts, and operations. These insights can help you keep up with emerging treatments and technologies, ensure you are not lagging behind competitors, and identify potential partnerships—all of which ensure you maintain a competitive advantage.

Competitor analysis is easy to do in the AlphaSense platform. Simply search for your competitor on the platform and explore the company tearsheet, which provides information on market cap, revenue, key topics from earnings transcripts, segments, other competitors, and analyst forecasts.

Competitor Benchmarking

Competitive benchmarking involves comparing your company's performance metrics against industry peers to identify areas of strength or improvement. In the pharma and biotech sectors, this means evaluating R&D expenditure, time-to-market for new drugs, pricing decisions, and clinical trial updates.

By benchmarking against competitors, biotech and pharmaceutical companies can set realistic goals, refine strategies, and make informed decisions to enhance their competitive edge in drug development and commercialization.

In the AlphaSense platform, you can create a watchlist for all your competitors and set real-time alerts to consistently stay up to date with the companies you are tracking. You can then establish the specific topics or disease areas that you would like to monitor across your competitive peer set. The Trending Topics module in the dashboard automatically shows the most important, talked-about phrases found across earnings calls, conferences, and company presentations.

Competitive Landscape Analysis

A comprehensive understanding of the competitive landscape is essential in pharma and biotech. This involves mapping out existing and potential competitors, analyzing their portfolios, and assessing the impact of market trends.

In these industries, factors such as patent expirations, market share for specific disease treatments/drugs, regulatory shifts, and emerging therapeutic approaches play a significant role. A robust competitive landscape analysis helps companies anticipate challenges, spot collaboration and BD&L (business development & licensing) opportunities, and strategically positions them for success.

AlphaSense makes this entire process faster and easier with our aggregated library of regulatory content from publications like ClinicalTrials.gov, FDA, EMA, and PubMed, as well as our AI search technology which works to filter out the noise and ensures you extract only the most relevant and actionable insights from sources.

Learn how a Swiss multinational manufacturing company in the biotech, pharma, and nutrition sectors uses AlphaSense to conduct thorough competitive landscape analysis.

Competitive Monitoring

Continuous monitoring of the competitive environment is vital for both biotech and pharma companies to adapt to rapid changes in the industry. This includes real-time tracking of competitor activities, clinical trial updates, M&A deals, and market trends.

You must be aware of your peers’ drug approvals and BD&L, as well as any drugs or treatments in the pipeline—so that you can be proactive, rather than reactive, in your strategic planning.

In the AlphaSense platform, you can build custom watchlists for competitor companies, so that you can be the first to know any new developments happening at those companies. Our AI company recognition feature enables you to easily extract data such as market share, pricing benchmarks, and company performance for each company of interest. Additionally, our newest generative AI feature, Smart Summaries, instantly summarizes your competitors’ earnings transcripts so you can shave precious time off earnings analysis.

Learn how 3T Biosciences, a small immunotherapy company, used AlphaSense to gain comprehensive insights and maximize their research — within budget constraints.

How AlphaSense Takes Your Competitive Intelligence Further

Leading healthcare and pharma companies trust AlphaSense as their all-in-one market intelligence tool that helps them maximize efficiency, keep on pace with innovation, and stay on the leading edge.

Here’s what sets AlphaSense apart from other market intelligence solutions:

Aggregated Research

AlphaSense houses over 10,000 trusted content sources, including but not limited to:

Company documents including SEC and global filings, earnings transcripts, company presentations, press releases, event transcripts, and more
Industry research from top Wall Street firms, including Bank of America, Cowen, JPMorgan, Barclays, Jefferies, Morgan Stanley, and Goldman Sachs
Unique pharmaceutical industry expert perspectives, including those of doctors, competitors, distributors, and World Health Organization employees
News outlets including medical journals, RSS feeds, business news, and market news
Company and competitor websites
Government and regulatory data, including drug approvals and clinical trial filings

This includes two content sets exclusive to AlphaSense:

Wall Street Insights®– a leading collection of broker research covering global sector themes, industries, and companies from 1,000 sell-side and independent firms
Expert Insights– 185,000+ transcripts of one-on-one calls with key opinion leaders, customers, professionals, competitors, and former and current executives

Our content includes everything you need to monitor clinical trials, drug pipelines, track new developments and competitor moves, and assess deal-making opportunities.

Semantic Search

With our AI search technology, you no longer have to manually CTRL-F through fragmented research documents and regulatory reports. Instead, our AI automatically recognizes what you are looking for and surfaces results that directly match your search intent—while filtering out excessive noise. This means you can speed up your research and be more confident in the accuracy and comprehensiveness of your results.

Our patented AI search feature, Smart Synonyms™, identifies phrases and keywords that are meaningfully related to provide relevant and useful data for your search query. For example, searching “medtech” will also surface results for “medical technology” and “healthcare technology.” Searching “Ozempic” will also surface results for “Wegovy”, “Rybelsus”, and “semaglutide.” Our synonym recognition technology mitigates the risk of missing critical insights or information sources.

Sentiment Analysis

Our sentiment analysis andnatural language processing (NLP) technology analyzes how the market feels about a given company, industry, or topic and color-codes positive and negative sentiment for easy recognition as you browse documents and search results. These AI features work in seconds, saving hours previously spent combing through dozens of earnings reports.

Sentiment analysis is instrumental in earnings research, as it uncovers subtle shifts in a competing company’s messaging on relevant topics and themes.

Generative AI

consulting market research artificial intelligence smart summaries

Unlike other consumer-grade generative AI (genAI) tools trained on publicly available data, AlphaSense takes an entirely different approach. Our industry-leading suite of generative AI tools is purpose-built to deliver business-grade insights and leans on 10+ years of AI tech development.

Our suite of tools currently includes:

Smart Summaries– This feature allows you to glean instant earnings insights—reducing time spent on research during earnings season, quickly capture company outlook, and generate an expert-approved SWOT analysis straight from former competitors, partners, and employees.
Enterprise Intelligence– This is a first-of-its-kind knowledge management offering that delivers AlphaSense’s AI-powered search and summarization capabilities to customers’ internal organizational knowledge.
AlphaSense Assistant(in beta) – Assistant is a generative AI chat experience that transforms how users can extract insights from hundreds of millions of premium content sources.

Our pharma and biotech customers use our generative AI capabilities to: